Cardiovascular Blind Spots and How Cleerly Is Changing the Game
In The Future of Medicine Podcast, Aaron Wenzel, MD, and Jennifer Justus, MSN, APRN, FNP-C dive into how Cleerly has revolutionized their ability to...
1 min read
Cleerly : April 6, 2022
Read on to learn more about a recent Health Professional Radio interview, featuring Dr. James “Jim” K. Min.
Interview by Health Professional Radio
In this episode, of Health Professional Radio, Dr. James “Jim” K. Min, CEO of Cleerly Health, a company whose mission is to up level the standard approaches to monitoring heart disease that have been used for decades, discusses its advanced non-invasive CT imaging. The advanced imaging allows physicians to monitor and characterize atherosclerosis (plaque) buildup, the primary disease that causes heart attacks, to accurately determine a patient’s risk of a heart attack.
Dr. Min shares how this approach is more effective and efficient compared to historical manual tests, how it is helping patients identify their cardiovascular diseases and develop a treatment plan and how the healthcare system needs to use advanced imaging to prevent heart disease, similar to how it’s done in cancer care.
Listen to the full interview HERE.
In The Future of Medicine Podcast, Aaron Wenzel, MD, and Jennifer Justus, MSN, APRN, FNP-C dive into how Cleerly has revolutionized their ability to...
Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...
Selected from more than 10,000 private healthcare companies, Cleerly is named one of CB Insight’s Digital Health 50 based on R&D, Mosaic scores,...
Selected from more than 10,000 private healthcare companies, Cleerly is named one of CB Insight’s Digital Health 50 based on R&D, Mosaic scores,...
The hires come in the wake of completing a $43 million series B round of funding this summer.